Blue Horseshoe Stocks: PZOO Post-Market News

Pazoo, Inc. PZOO

We wanted to send out an afternoon update on PZOO after noticing a new PR hitting the wires after hours today. We tagged the stock as a bottom-watch play in this morning’s extended watchlist, noting that it had been flirting with 3-month lows. PZOO responded by producing a respectable 14% intraday move from .0057-.0065, and holding the majority of its ground with a .0063 close.

Those of our readers that have been following Pazoo’s story along with us recently will recall PZOO’s subsidiary, CannabisKing Distribution, which was formed this spring. The company appears to be making steady strides in the development of this branch of its business over the past couple of weeks. On June 25th, they announced that CannabisKing struck a distribution deal for Accuvape vaporizers and accesories. Today, we’re learning that the rights have been acquired to distribute a sanitation system for legal marijuana grow operations that evidently kills mold, mildew and all sorts of harmful pathogens that can ruin a crop.

We suggest our readers take a look at the PR, and continue to stay tuned for further updates on PZOO:

WHIPPANY, N.J., July 9, 2015 /PRNewswire/ — Pazoo, Inc. (PZOO) announced today it has signed a distribution agreement with Pure Grow Systems, LLC, a subsidiary of FastFunds Financial Corporation (FFFC). The terms of the agreement give Pazoo the right to distribute the Pure Grow Systems product line to cannabis-related companies in select states in the United States. >> FULL PR


Blue Horseshoe Stocks: DRMC Review & More

Definitive Rest Mattress Co. DRMC

To start things off this morning we wanted to provide an update on DRMC, which made an excellent intraday move to start the session yesterday.

When last we looked in on DRMC at the end of the short week on Thursday, we had just observed a decent 35% intraday run in the prior session, and left our readers with a closing thought that would end up serving us well. We noted that the stock had been trading relatively thinly as a general rule, and that “a pickup in buying pressure could really send DRMC for a ride, so we’ll keep watch for that, and for the stock to continue maintaining support above the 50DMA”

It’s a good thing that we did keep watch, because the stock would both maintain above the 50DMA (.002), and see the necessary surge in volume to make its mark. Starting out from a morning low of .0037, DRMC bulled its way up to a high of .0079 in roughly the first 45 minutes of trading. That worked out to an incredible single session rip totaling 113%  From our observed low on Tuesday (.0022), yesterday’s high registered as a two-session swing of 259%

The excellent spike in volume came in conjunction with the company’s announcement that it was adding Carbon Fiber to its list of manufacturing technologies, as well as launching its new website. >>View PR


Regen BioPharma, Inc. RGBP

RGBP is hitting our scanner this morning for a couple of reasons. Firstly, the company released a positive PR regarding one of its new drug candidates, HemaXellerate. The results of an animal study conducted at the behest of the FDA proved promising with regard to the treatment’s path to approval for clinical trials.

Secondly, RGBP represents a potential opportunity as a play trading near a recent relative bottom. We’re going to look for RGBP to record higher highs and higher lows. and hold support above Tuesday’s swing low of .12 in order for us to remain interested.


Extended Watchlist:
RMGN, FRO, MM, NQ, PZOO(Testing 3mo. Lows, on Bottom-Watch)